Quantcast

Latest BD Diagnostics Stories

2011-08-03 07:00:00

BALTIMORE and CAMBRIDGE, England, Aug. 3, 2011 /PRNewswire/ -- BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Lab21, a global leader in personalized healthcare, announced today a collaboration to develop a state-of-the-art molecular diagnostic assay to detect the life-threatening Aspergillus fungus using the new fully automated BD MAX(TM) Molecular Testing System. "The potential to detect Aspergillus in blood using...

2011-08-02 05:00:00

FRANKLIN LAKES, N.J., Aug. 2, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.014 billion for the third fiscal quarter ended June 30, 2011, representing an increase of 10.0 percent from the prior-year period. On a foreign currency-neutral basis, revenues increased 4.8 percent. "We are pleased with our solid results this quarter, with all three segments contributing to growth," said...

2011-07-26 15:01:00

FRANKLIN LAKES, N.J., July 26, 2011 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, in accordance with its long-term succession planning, it has elected Vincent A. Forlenza as Chief Executive Officer and President, effective October 1, 2011. Mr. Forlenza will also become a member of the Board at that time. Also effective October 1, current BD Chairman and Chief Executive Officer...

2011-05-19 13:34:00

BALTIMORE, May 19, 2011 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the U.S. launch of the BD MAX(TM) for use as an open system. BD MAX is the first and only fully automated, bench-top molecular system designed to perform a broad range of molecular tests. This includes in vitro diagnostic (IVD) assays, but also user-defined protocols and life science research applications. The BD MAX System gives clinical laboratory...

2011-05-09 07:00:00

BALTIMORE and LIEGE, Belgium, May 9, 2011 /PRNewswire/ -- BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Diagenode SA, an international biotech company based in Belgium, announced today an agreement to co-develop seven initial molecular diagnostic assays on the BD MAX(TM) System for pathogens associated with respiratory, enteric and central nervous system diseases. "Our agreement with Diagenode represents the first...

2011-04-26 15:01:00

FRANKLIN LAKES, N.J., April 26, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $1.922 billion for the second fiscal quarter ended March 31, 2011, representing an increase of 6.8 percent from the prior-year period. On a foreign currency-neutral basis, revenue increased 4.6 percent, despite an unfavorable comparison to the prior year of about 2.3 percentage points due to strong sales...

2011-02-07 15:04:00

FRANKLIN LAKES, N.J., Feb. 7, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $1.842 billion for the first fiscal quarter ended December 31, 2010, representing a decrease of 1.4 percent from the prior-year period. On a foreign currency-neutral basis, revenue decreased 1.5 percent. The revenue decline reflects an unfavorable comparison to the prior year of about 4 percentage points due...

2011-02-04 06:15:00

RALEIGH, N.C., Feb. 4, 2011 /PRNewswire-USNewswire/ -- The National Cancer Coalition (NCC) and BD (Becton, Dickinson and Company), a leading global medical technology company, are pleased to announce the implementation of a cervical cancer early detection program to benefit 75,000 underserved women in Peru. With a goal to reduce the high cervical cancer mortality levels in the mountainous region surrounding Cusco, this extensive three-year program is set to conduct liquid-based cytology...

2011-01-03 14:00:00

DURHAM, N.C., Jan. 3, 2011 /PRNewswire/ -- Clinicians may soon have a new tool in the diagnosis and treatment of Herpes Simplex Viruses (HSV) - one of the most common sexually transmitted infections in the world. BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it filed for U.S. Food and Drug Administration (FDA) 510(k) clearance for the first fully automated molecular tests to diagnose and differentiate HSV types 1 and 2. "When caring...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related